Plasma II-hydroxycorticosteroids in affective disorders

Brooksbank, B. W. L.; Coppen, Alec; Brooksbank, B W; Coppen, A
April 1967
British Journal of Psychiatry;Apr67, Vol. 113 Issue 497, p395
Academic Journal
journal article
The article examines the use of plasma 11-hydroxycorticosteroids (PLASMA 11-OHCS) in treating patients with affective disorders. Concentrations of plasma 11-OHCS were measured at standardized times to test for gross disturbances in diurnal rhythm. Twenty-nine patients were investigated with a mean age of 52.8 years. Electroconvulsive therapy and anti-depressive drugs were the methods used in the study. No evidence was found regarding the difference in the pattern change regarding the use of both methods. Other results of the study were also discussed.


Related Articles

  • Zaburzenia snu - przyczyna czy skutek depresji? Haeitzman, Janusz // Psychiatria Polska;2009, Vol. 43 Issue 5, p499 

    Sleep disturbances are a very sensitive indicator, which allows identifying various psychic illnesses, especially depression. Irrelevant of the very nature of sleep disturbances, their presence can tell us about the onset of depression or its ending. The mechanism of sleep disturbances seems to...

  • Post-stroke emotional incontinence or bipolar disorder? Mnif, Leila; Sellami, Rim; Masmoudi, Jawaher // Neuropsychiatric Disease & Treatment;Jul2016, Vol. 12, p1883 

    Introduction: Post-stroke emotional incontinence and bipolar disorder are two disorders that involve the dysfunction of brain structures responsible for emotional regulation. The objective of this work is to study the links between these disorders through a clinical case. Case report: We present...

  • Performance of the dexamethasone suppression test in depressive illness according to ICD and DSM-III classification systems. Watkins, Sarah; Harris, Brian; Cook, Nigel; Thomas, Roger; Riad-Fahmy, Diana; Watkins, S; Harris, B; Cook, N; Thomas, R; Riad-Fahmy, D // British Journal of Psychiatry;Apr88, Vol. 152, p554 

    The performance of the dexamethasone suppression test was assessed in 90 consecutive admissions with a diagnosis of depression, categorised according to two classification systems (DSM-III and ICD-9). Non-suppression was found in most of the diagnostic categories, but there was a highly...

  • AMITRIPTYLINE IN DEPRESSIVE STATES: SIX-MONTH TREATMENT RESULTS. Hordern, Anthony; Burt, C. G.; Gordon, W. F.; Holt, N. F.; HORDERN, A // British Journal of Psychiatry;Sep64, Vol. 110 Issue 468, p641 

    The article seeks to examine a number of problems in the treatment of depressive states by means of a blind trial to compare the effectiveness of amitriptyline and imipramine. Taking in conjunction with the findings reported in earlier papers, the results convincingly suggest that antidepressant...

  • Variations in II-hydroxycorticosteroids in depression and manic-depressive psychosis. Hullin, R. P.; Bailey, A. D.; McDonald, R.; Dransfield, G. A.; Milne, H. B. // British Journal of Psychiatry;Jun67, Vol. 113 Issue 499, p593 

    The article presents a study which examines the variation in plasma II-hydroxycorticosteroids in patients with mental depression and manic-depressive psychosis. It aims to determine whether there was a difference between the plasma II-hydroxycorticosteroids of a group of normal people who...

  • Development of a questionnaire-based decision rule for classifying depressed patients. Pilowsky, I.; Boulton, D. M. // British Journal of Psychiatry;Jun70, Vol. 116 Issue 535, p647 

    The article discusses the development of a questionnaire-based decision rule for classifying depressed patients. A total of 45 patients were classified into class A, B and C. Class A comprised of mixed group of reactive depressions, Class B corresponded to endogenous depression while Class C...

  • Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Esparon, J.; Kolloori, J.; Naylor, G. J.; Smith, A. M.; Hopwood, S. E.; McHarg, A M; Smith, A H // British Journal of Psychiatry;Jun86, Vol. 148, p723 

    A double-blind cross-over trial of depot flupenthixol in recurrent manic depressive psychosis was carried out. All patients continued on lithium. Eleven patients completed the two-year trial. Flupenthixol appeared to have no prophylactic effect.

  • Does the dexamethasone suppression test predict antidepressant treatment success? Coppen, Alec; Millin, Philip; Harwood, Janet; Wood, Keith; Coppen, A; Milln, P; Harwood, J; Wood, K // British Journal of Psychiatry;Mar85, Vol. 146, p294 

    The 1 mg dexamethasone suppression test (DST) was carried out in patients with a major depressive illness in order to establish whether the results of this test, given before antidepressant or ECT treatment, could predict eventual therapeutic outcome. No significant difference could be detected...

  • A review of continuation and maintenance electroconvulsive therapy. Rabheru, Kiran; Persad, Emmanuel; Rabheru, K; Persad, E // Canadian Journal of Psychiatry;Jun1997, Vol. 42 Issue 5, p476 

    Background: Many patients with major psychiatric disorders who are severely ill, medication-resistant, or medication-intolerant respond more reliably and quickly to a course of electroconvulsive therapy (ECT). The management of such patients after successful treatment with ECT is of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics